Temple Rock Holdings Inc.

BIOSIGN MASTER DISTRIBUTOR ALQAEM INCREASES INITIAL UFIT ORDER BY 150%
TORONTO, Feb. 7 /CNW/ -Biosign Technologies Inc. (TSXV: BIO) announces that the Health Care Division of ALQAEM International FZE has increased their initial order for Biosign's pulse acquisition devices (UFIT® PAD) to 500,000 USD. Biosign plans to start shipping UFIT® to the MENA region this quarter. Under the terms of the Exclusive Master Distributor Agreement between Biosign and ALQAEM, this initial order should generate, once fully deployed, an annual recurring revenue for Biosign in excess of 2 million USD. MORE>>